Does the Use of Proton Pump Inhibitors Increase the Risk of Pancreatic Cancer? A Systematic Review and Meta-Analysis of Epidemiologic Studies

Background: One of the most frequently used medications for treating gastrointestinal disorders is proton pump inhibitor (PPI), which reportedly has potential adverse effects. Although the relationship between the use of PPIs and the risk of pancreatic cancer has been extensively investigated, the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Hee-Eun, Kim, A-Sol, Kim, Mi-Rae, Ko, Hae-Jin, Jung, Min Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463819/
https://www.ncbi.nlm.nih.gov/pubmed/32784492
http://dx.doi.org/10.3390/cancers12082220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463819/
https://www.ncbi.nlm.nih.gov/pubmed/32784492
http://dx.doi.org/10.3390/cancers12082220

Ejemplares similares